{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T12:13:32Z","timestamp":1788178412991,"version":"build-2803163510"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Critical Care"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.jcrc.2026.155471","type":"journal-article","created":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T17:00:23Z","timestamp":1770483623000},"page":"155471","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Current perspectives in cardiogenic shock"],"prefix":"10.1016","volume":"93","author":[{"given":"Ounci","family":"Es-saad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wincy","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Messina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle S.","family":"Chew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"16","key":"10.1016\/j.jcrc.2026.155471_bb0005","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1016\/j.jacc.2025.02.018","article-title":"2025 concise clinical guidance: an ACC expert consensus statement on the evaluation and management of cardiogenic shock","volume":"85","author":"Sinha","year":"2025","journal-title":"JACC"},{"issue":"9","key":"10.1016\/j.jcrc.2026.155471_bb0010","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.jacc.2022.01.018","volume":"79","author":"Naidu","year":"2022","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"10.1016\/j.jcrc.2026.155471_bb0015","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.acvd.2024.07.059","article-title":"Ten-year trends in characteristics, management and outcomes of patients admitted with cardiogenic shock in the ACTION-SHOCK cohort","volume":"117","author":"Sulman","year":"2024","journal-title":"Arch Cardiovasc Dis"},{"issue":"9","key":"10.1016\/j.jcrc.2026.155471_bb0020","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1007\/s00134-025-08049-y","article-title":"Cardiogenic shock: diagnosis, phenotyping and management","volume":"51","author":"M\u00f8ller","year":"2025","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.jcrc.2026.155471_bb0025","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1056\/NEJM199908263410901","article-title":"Early revascularization in acute myocardial infarction complicated by cardiogenic SHOCK. SHOCK investigators. Should we emergently revascularize occluded coronaries for cardiogenic shock","volume":"341","author":"Hochman","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcrc.2026.155471_bb0030","article-title":"Mortality trends related to cardiogenic shock in heart failure patients aged 25 and older across the United States: a study utilizing the CDC WONDER database from 1999 to 2023","volume":"59","author":"Muhammad","year":"2025","journal-title":"IJC Heart Vasc"},{"issue":"14","key":"10.1016\/j.jcrc.2026.155471_bb0035","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1161\/CIRCULATIONAHA.123.064527","article-title":"Standardized definitions for cardiogenic shock research and mechanical circulatory support devices: Scientific expert panel from the Shock Academic Research Consortium (SHARC)","volume":"148","author":"Waksman","year":"2023","journal-title":"Circulation"},{"issue":"11","key":"10.1016\/j.jcrc.2026.155471_bb0040","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1007\/s00134-025-08137-z","article-title":"ESICMs guidelines on circulatory shock and hemodynamic monitoring 2025","volume":"51","author":"Monnet","year":"2025","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.jcrc.2026.155471_bb0045","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.120.007678","article-title":"Defining shock and preshock for mortality risk stratification in cardiac intensive care unit patients","volume":"14","author":"Jentzer","year":"2021","journal-title":"Circ Heart Fail"},{"issue":"5","key":"10.1016\/j.jcrc.2026.155471_bb0050","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/S0002-9343(00)00310-7","article-title":"Acute myocardial infarction complicated by systemic hypoperfusion without hypotension: report of the SHOCK trial registry","volume":"108","author":"Menon","year":"2000","journal-title":"Am J Med"},{"issue":"11 Pt 1","key":"10.1016\/j.jcrc.2026.155471_bb0055","article-title":"S. Identifying cardiogenic shock sub-phenotypes with machine learning: A multicenter study combining clinical and echocardiographic data","volume":"4","author":"Ghionzoli","year":"2025","journal-title":"JACC Adv"},{"issue":"10","key":"10.1016\/j.jcrc.2026.155471_bb0060","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1016\/j.jchf.2023.05.007","article-title":"Clinical course of patients in cardiogenic shock stratified by phenotype","volume":"11","author":"Zweck","year":"2023","journal-title":"JACC Heart Fail"},{"issue":"4","key":"10.1016\/j.jcrc.2026.155471_bb0065","first-page":"1006","article-title":"Validation of cardiogenic shock phenotypes in a mixed cardiac intensive care unit population","volume":"99","author":"Jentzer","year":"2022","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.jcrc.2026.155471_bb0070","article-title":"Identifying biomarker-driven subphenotypes of cardiogenic shock: analysis of prospective cohorts and randomized controlled trials","volume":"79","author":"Soussi","year":"2024","journal-title":"EClinicalMedicine"},{"issue":"10","key":"10.1016\/j.jcrc.2026.155471_bb0075","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1016\/j.jchf.2023.06.024","article-title":"Precision medicine in cardiogenic shock: we are almost there!","volume":"11","author":"Mebazaa","year":"2023","journal-title":"JACC Heart Fail"},{"issue":"13","key":"10.1016\/j.jcrc.2026.155471_bb0080","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1001\/jama.294.13.1625","article-title":"Evaluation study of congestive heart failure and pulmonary artery catheterization effectiveness: the ESCAPE trial","volume":"294","author":"Binanay","year":"2005","journal-title":"JAMA"},{"issue":"8 Pt 1","key":"10.1016\/j.jcrc.2026.155471_bb0085","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.jchf.2023.04.007","article-title":"Pulmonary artery catheter use and mortality in the cardiac intensive care unit","volume":"11","author":"Kadosh","year":"2023","journal-title":"JACC Heart Fail"},{"issue":"17","key":"10.1016\/j.jcrc.2026.155471_bb0090","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.019843","article-title":"Right heart catheterization in cardiogenic shock is associated with improved outcomes: insights From the nationwide readmissions database","volume":"10","author":"Ranka","year":"2021","journal-title":"J Am Heart Assoc"},{"issue":"11","key":"10.1016\/j.jcrc.2026.155471_bb0095","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.116.003226","article-title":"Variation in hospital use and outcomes associated with pulmonary artery catheterization in heart failure in the United States","volume":"9","author":"Khera","year":"2016","journal-title":"Circ Heart Fail"},{"issue":"5","key":"10.1016\/j.jcrc.2026.155471_bb0100","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1097\/SHK.0000000000002290","article-title":"Invasive hemodynamic monitoring with pulmonary artery catheter in sepsis-associated cardiogenic shock","volume":"61","author":"Sato","year":"2024","journal-title":"Shock"},{"issue":"11","key":"10.1016\/j.jcrc.2026.155471_bb0105","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1007\/s12630-021-02083-2","article-title":"Pulmonary artery catheterization in patients with cardiogenic shock: a systematic review and meta-analysis","volume":"68","author":"Chow","year":"2021","journal-title":"Can J Anaesth"},{"key":"10.1016\/j.jcrc.2026.155471_bb0110","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.carrev.2023.04.008","article-title":"Clinical impact of pulmonary artery catheter in patients with cardiogenic shock: a systematic review and meta-analysis","volume":"55","author":"Yoo","year":"2023","journal-title":"Cardiovasc Revasc Med"},{"issue":"11","key":"10.1016\/j.jcrc.2026.155471_bb0115","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.jchf.2020.08.012","article-title":"Complete hemodynamic profiling with pulmonary artery catheters in cardiogenic shock is associated with lower in-hospital mortality","volume":"8","author":"Garan","year":"2020","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.jcrc.2026.155471_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2022.108230","article-title":"Pharmacological treatment of cardiogenic shock - a state of the art review","volume":"240","author":"Bruno","year":"2022","journal-title":"Pharmacol Ther"},{"issue":"15","key":"10.1016\/j.jcrc.2026.155471_bb0125","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.123.029787","article-title":"State of shock: Contemporary vasopressor and inotrope use in cardiogenic shock","volume":"12","author":"Bloom","year":"2023","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jcrc.2026.155471_bb0130","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.125.044373","article-title":"Contemporary practice patterns of vasoactive use in cardiogenic shock in the AHA cardiogenic shock registry","author":"Patel","year":"2025","journal-title":"J Am Heart Assoc"},{"issue":"1","key":"10.1016\/j.jcrc.2026.155471_bb0135","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1186\/s13054-016-1387-1","article-title":"CardShock study investigators. Current real-life use of vasopressors and inotropes in cardiogenic shock - adrenaline use is associated with excess organ injury and mortality","volume":"20","author":"Tarvasm\u00e4ki","year":"2016","journal-title":"Crit Care"},{"issue":"2","key":"10.1016\/j.jcrc.2026.155471_bb0140","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jacc.2018.04.051","article-title":"Collaborators. Epinephrine versus norepinephrine for cardiogenic shock after acute myocardial infarction","volume":"72","author":"Levy","year":"2018","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"10.1016\/j.jcrc.2026.155471_bb0145","first-page":"2022","article-title":"Epinephrine and short-term survival in cardiogenic shock: an individual data meta-analysis of 2583 patients. Intensive care med. 2018 Jun;44(6):847-856. Doi:10.1007\/s00134-018-5222-9. Epub 2018 Jun 1","volume":"44","author":"L\u00e9opold","year":"2018","journal-title":"Erratum in: Int Care Med"},{"issue":"9","key":"10.1016\/j.jcrc.2026.155471_bb0150","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1056\/NEJMoa0907118","article-title":"SOAP II Investigators. Comparison of dopamine and norepinephrine in the treatment of shock","volume":"362","author":"De Backer","year":"2010","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.jcrc.2026.155471_bb0155","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1016\/j.amjcard.2005.07.076","article-title":"Effect of vasopressin on hemodynamics in patients with refractory cardiogenic shock complicating acute myocardial infarction","volume":"96","author":"Jolly","year":"2005","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jcrc.2026.155471_bb0160","author":"Indrambarya"},{"issue":"1","key":"10.1016\/j.jcrc.2026.155471_bb0165","doi-asserted-by":"crossref","first-page":"R20","DOI":"10.1186\/cc6794","article-title":"Vasopressin impairs brain, heart and kidney perfusion: an experimental study in pigs after transient myocardial ischemia","volume":"12","author":"M\u00fcller","year":"2008","journal-title":"Crit Care"},{"issue":"3","key":"10.1016\/j.jcrc.2026.155471_bb0170","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1002\/ehf2.13893","article-title":"Norepinephrine use in cardiogenic shock patients is associated with increased 30 day mortality","volume":"9","author":"Lu","year":"2022","journal-title":"ESC Heart Fail"},{"issue":"3","key":"10.1016\/j.jcrc.2026.155471_bb0175","first-page":"650","article-title":"National cardiogenic shock initiative investigators. Vasopressors independently associated with mortality in acute myocardial infarction and cardiogenic shock","volume":"99","author":"Basir","year":"2022","journal-title":"Catheter Cardiovasc Interv"},{"issue":"6","key":"10.1016\/j.jcrc.2026.155471_bb0180","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1056\/NEJMoa2026845","article-title":"Milrinone as compared with dobutamine in the treatment of cardiogenic shock","volume":"385","author":"Mathew","year":"2021","journal-title":"N Engl J Med"},{"issue":"21","key":"10.1016\/j.jcrc.2026.155471_bb0185","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1056\/NEJMoa1616218","article-title":"LEVO-CTS investigators. Levosimendan in patients with left ventricular dysfunction undergoing cardiac surgery","volume":"376","author":"Mehta","year":"2017","journal-title":"N Engl J Med"},{"issue":"17","key":"10.1016\/j.jcrc.2026.155471_bb0190","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1001\/jama.297.17.1883","article-title":"Levosimendan vs dobutamine for patients with acute decompensated heart failure: the SURVIVE randomized trial","volume":"297","author":"Mebazaa","year":"2007","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.jcrc.2026.155471_bb0195","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1001\/jama.2025.19843","article-title":"LEVOECMO trial group and the international ECMO network (ECMONet). Levosimendan to facilitate weaning from ECMO in patients with severe cardiogenic shock: the LEVOECMO randomized clinical trial","volume":"335","author":"Combes","year":"2026","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.jcrc.2026.155471_bb0200","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1186\/s13054-021-03706-2","article-title":"CAPITAL DOREMI investigators. Impact of baseline beta-blocker use on inotrope response and clinical outcomes in cardiogenic shock: a subgroup analysis of the DOREMI trial","volume":"25","author":"Di Santo","year":"2021","journal-title":"Crit Care"},{"issue":"2","key":"10.1016\/j.jcrc.2026.155471_bb0205","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1002\/ejhf.3162","article-title":"Medical therapy of cardiogenic shock: contemporary use of inotropes and vasopressors","volume":"26","author":"Riccardi","year":"2024","journal-title":"Eur J Heart Fail"},{"issue":"9","key":"10.1016\/j.jcrc.2026.155471_bb0210","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1001\/jamacardio.2017.2198","article-title":"National Heart Lung and blood institute heart failure clinical research network. Efficacy and safety of spironolactone in acute heart failure: the ATHENA-HF randomized clinical trial","volume":"2","author":"Butler","year":"2017","journal-title":"JAMA Cardiol"},{"issue":"3","key":"10.1016\/j.jcrc.2026.155471_bb0215","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1161\/CIRCULATIONAHA.118.038201","article-title":"IABP-SHOCK II: long-term 6-year outcome","volume":"139","author":"Thiele","year":"2019","journal-title":"Circulation"},{"issue":"14","key":"10.1016\/j.jcrc.2026.155471_bb0220","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1056\/NEJMoa2307227","article-title":"ECLS-SHOCK","volume":"389","author":"Thiele","year":"2023","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.jcrc.2026.155471_bb0225","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s12947-017-0109-4","article-title":"Left ventricular outflow tract velocity time integral outperforms ejection fraction and doppler-derived cardiac output for predicting outcomes in a select advanced heart failure cohort","volume":"15","author":"Tan","year":"2017","journal-title":"Cardiovasc Ultrasound"},{"issue":"16","key":"10.1016\/j.jcrc.2026.155471_bb0230","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1016\/j.jacc.2018.07.074","article-title":"Cardiac shock care centers: JACC review topic of the week","volume":"72","author":"Rab","year":"2018","journal-title":"JACC"},{"issue":"15","key":"10.1016\/j.jcrc.2026.155471_bb0235","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1056\/NEJMoa2312572","article-title":"DanGer shock investigators. Microaxial flow pump or standard care in infarct-related cardiogenic shock","volume":"390","author":"M\u00f8ller","year":"2024","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.jcrc.2026.155471_bb0240","article-title":"Mechanical circulatory support devices in acute myocardial infarction-cardiogenic shock: current studies and future directions","volume":"2","author":"Jentzer","year":"2023","journal-title":"J Soc Cardiovasc Angiogr Interv"},{"issue":"14","key":"10.1016\/j.jcrc.2026.155471_bb0245","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.020085","article-title":"Phenotyping Cardiogenic Shock","volume":"10","author":"Zweck","year":"2021","journal-title":"J Am Heart Assoc"},{"issue":"10466","key":"10.1016\/j.jcrc.2026.155471_bb0250","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1016\/S0140-6736(24)01818-X","article-title":"Cardiogenic shock","volume":"404","author":"L\u00fcsebrink","year":"2024","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.jcrc.2026.155471_bb0255","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1007\/s00134-024-07618-x","article-title":"Management of cardiogenic shock: state-of-the-art","volume":"50","author":"Jung","year":"2024","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.jcrc.2026.155471_bb0260","first-page":"1","article-title":"Clinical guideline for treating acute respiratory insufficiency with invasive ventilation and extracorporeal membrane oxygenation: updated evidence- based recommendations for choosing modes and setting parameters of mechanical ventilation","author":"Hohmann","year":"2025","journal-title":"Respiration"},{"key":"10.1016\/j.jcrc.2026.155471_bb0265","article-title":"Acute renal replacement therapy in cardiogenic shock: prognostic impact of timing, modality, and indications - insights from the FRENSHOCK study","volume":"92","author":"Florens","year":"2025","journal-title":"J Crit Care"},{"key":"10.1016\/j.jcrc.2026.155471_bb0270","article-title":"VASO-SHOCK group study. Timing of vasopressin initiation influences renal outcomes in mixed cardiogenic-Vasodilatory Shock Supported by VA-ECMO","author":"Pierre-Gr\u00e9goire","year":"2025","journal-title":"Anaesth Crit Care Pain Med"},{"issue":"5","key":"10.1016\/j.jcrc.2026.155471_bb0275","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1001\/jama.2021.24776","volume":"327","author":"Levy","year":"2022","journal-title":"JAMA"},{"issue":"12","key":"10.1016\/j.jcrc.2026.155471_bb0280","doi-asserted-by":"crossref","first-page":"e2476","DOI":"10.1097\/CCM.0000000000006897","article-title":"Impact of left ventricular venting on acute brain injury in patients with cardiogenic shock: an extracorporeal life support organization registry analysis","volume":"53","author":"Feng","year":"2025","journal-title":"Crit Care Med"},{"issue":"12","key":"10.1016\/j.jcrc.2026.155471_bb0285","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.125.012890","article-title":"Plasma proteome analysis identifies vascular endothelial growth factor receptor 1 as a prognostic biomarker in cardiogenic shock","volume":"18","author":"Jung","year":"2025","journal-title":"Circ Heart Fail"},{"issue":"38","key":"10.1016\/j.jcrc.2026.155471_bb0290","doi-asserted-by":"crossref","first-page":"3859","DOI":"10.1093\/eurheartj\/ehad545","article-title":"Dipeptidyl peptidase 3 plasma levels predict cardiogenic shock and mortality in acute coronary syndromes","volume":"44","author":"Wenzl","year":"2023","journal-title":"Eur Heart J"},{"issue":"9","key":"10.1016\/j.jcrc.2026.155471_bb0295","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/S2213-2600(25)00084-0","article-title":"Optimising trial design for cardiogenic shock: insights from the sixth critical care clinical trialists workshop","volume":"13","author":"Kimmoun","year":"2025","journal-title":"Lancet Respir Med"},{"issue":"13","key":"10.1016\/j.jcrc.2026.155471_bb0300","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1016\/j.jacc.2021.07.044","article-title":"Critical care cardiology trials network Investigators. Management and outcomes of cardiogenic shock in cardiac ICUs with versus without shock teams","volume":"78","author":"Papolos","year":"2021","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"10.1016\/j.jcrc.2026.155471_bb0305","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacadv.2024.101047","article-title":"Resource utilization and costs associated with cardiogenic shock complicating myocardial infarction","volume":"3","author":"Parlow","year":"2024","journal-title":"JACC Adv"}],"container-title":["Journal of Critical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0883944126000493?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0883944126000493?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T11:14:24Z","timestamp":1788174864000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0883944126000493"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":61,"alternative-id":["S0883944126000493"],"URL":"https:\/\/doi.org\/10.1016\/j.jcrc.2026.155471","relation":{},"ISSN":["0883-9441"],"issn-type":[{"value":"0883-9441","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Current perspectives in cardiogenic shock","name":"articletitle","label":"Article Title"},{"value":"Journal of Critical Care","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcrc.2026.155471","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"155471"}}